In fact, the truncated GLI1 (tGLI1) splice variant presents a unique opportunity to validate a novel actionable target for gliomas and breast cancer brain metastases due to its tumor-specific expression and potent oncogenic effects. Here, GLI1 is linked to central nervous system cancer.